Corbenic Partners LLC Red Hill Biopharma Ltd. Transaction History

Corbenic Partners LLC

  • $380 Million
  • Q2 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 13, 2021
SELL
$4.55 - $10.36 $455 - $1,036
-100 Closed
0 $0
Q1 2021

Apr 14, 2021
SELL
$6.98 - $11.29 $2,792 - $4,516
-400 Reduced 80.0%
100 $1,000
Q4 2019

Jan 14, 2020
BUY
$5.76 - $7.35 $2,880 - $3,675
500 New
500 $3,000

Others Institutions Holding RDHL

# of Institutions
2
Shares Held
40.4K
Call Options Held
0
Put Options Held
0
View Full List

About RedHill Biopharma Ltd.

RDHL Quotes by TradingView
  • Ticker RDHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 63,823,500
  • Market Cap $23M
  • Description
  • RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...
More about RDHL
Track This Portfolio

Track Corbenic Partners LLC Portfolio

Follow Corbenic Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corbenic Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corbenic Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email